Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multi-factor designs. II. A design for identifying instruments with sample-to-sample carryover and drift.

B Schlain1, J S Krouwer

  • 1Ciba Corning Diagnostics Corp., Medfield, MA 02052.

Clinical Chemistry
|October 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How to improve total error modeling by accounting for error sources beyond imprecision and bias.

Clinical chemistry·2001
Same author

Testing claimed minimal detectable concentrations of in vitro medical diagnostic devices.

Clinical chemistry·2000
Same author

A stochastic approximation method for assigning values to calibrators.

Clinical chemistry·1998
Same author

Two-stage procedure for evaluating interassay carryover on random-access instruments.

Clinical chemistry·1996
Same author

A simple, graphical method to evaluate laboratory assays.

European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies·1995
Same author

Modification of NCCLS EP10 to include interference screening.

Clinical chemistry·1995

This study introduces a new assay design to detect subtle systematic errors like sample carryover and drift. This method is crucial for accurate measurements of analytes near zero, as demonstrated with thyrotropin measurements.

Area of Science:

  • Clinical Chemistry
  • Analytical Chemistry
  • Biomedical Assay Development

Background:

  • Accurate quantification of analytes is critical in clinical diagnostics, especially for those with decision points near zero.
  • Systematic errors, such as analyte drift and sample-to-sample carryover, can significantly impact assay accuracy.
  • Existing methods may not adequately address the simultaneous estimation of low-level drift and carryover.

Purpose of the Study:

  • To present a novel, nearly orthogonal two-level experimental design for simultaneously estimating drift and sample-to-sample carryover.
  • To demonstrate the utility of a weighted analysis approach within this design.
  • To highlight the importance of detecting these systematic errors in high-range analyte assays with low medical decision points.

Main Methods:

Related Experiment Videos

  • Implementation of a nearly orthogonal two-level experimental design.
  • Application of a weighted analysis technique to estimate drift and carryover.
  • Validation using a specific assay for thyrotropin (TSH).

Main Results:

  • The proposed design successfully estimated both drift and carryover simultaneously.
  • A low level of sample-to-sample carryover (0.08%) was detected.
  • Concentration-dependent negative drift was observed in the thyrotropin assay.
  • The method proved effective even with a small number of samples (32) in a single run.

Conclusions:

  • The described two-level design with weighted analysis provides a robust method for identifying and quantifying low-level systematic errors in bioassays.
  • This approach is particularly valuable for assays where accuracy near zero is critical, such as for thyrotropin.
  • The findings underscore the need for careful assay design to mitigate the impact of drift and carryover on clinical results.